Samsung Targets 77M Health Users for Open Healthcare Ecosystem at VivaTech 2026

The Quick Take

• Samsung Electronics announces an open collaboration strategy leveraging 77 million health users and 460 million SmartThings subscribers to dominate home healthcare
• At VivaTech 2026 in Paris, Samsung presented its Connected Care healthcare vision with startup partners, positioning the Samsung Health platform as a global ecosystem hub
• Samsung's open-partnership approach invites global startups to build on its user base, creating a platform network-effect strategy to preempt rivals in home health monitoring

Samsung Electronics has announced a strategic pivot toward open-platform healthcare collaboration, leveraging its 77 million Samsung Health users and 460 million SmartThings smart home subscribers as an ecosystem foundation. Unveiled at VivaTech 2026 in Paris — Europe's largest startup and technology conference — the strategy centers on attracting global health startups to build products that interoperate with Samsung's existing device and data infrastructure. The Connected Care vision positions Samsung's Mobile Experience division not as a standalone healthcare device maker but as a platform that aggregates health data, device connectivity, and third-party clinical applications into a unified home health environment.

The open-collaboration strategy has significant competitive and capital-flow implications. By opening its user base to external startups rather than building all healthcare capabilities internally, Samsung creates a developer moat that rivals Apple Health and Google Fit would find expensive to replicate at the same global scale. SamsungNext's investment activity — including portfolio companies Gels and Genration Labs — signals that Samsung is deploying venture capital to accelerate ecosystem density. For healthcare SaaS and medtech startups, a Samsung partnership or investment now represents a distribution pathway to hundreds of millions of existing smart home users, revaluing Samsung-affiliated companies' market expansion prospects.

The key forward signal is the rate at which qualified health startups join the Connected Care ecosystem and whether any receive material AUM from SamsungNext. The macro variable is global digital health regulation: GDPR-aligned health data governance in Europe and FDA software-as-medical-device rules in the US will determine which Connected Care features can be commercialized across geographies. Watch Samsung's Q3 earnings for any mobile health platform revenue line — the first indication of whether the ecosystem strategy is monetizing beyond device hardware margins. KOSPI and global tech ETF sentiment will also track Samsung's ability to differentiate its health narrative from Apple's established wearables-plus-watch ecosystem.

Synthesized from 2 sources.